Dr. Martin A. Schreiber, in this position (held since 2021), leverages his extensive experience as a Colonel in the U.S. Army Reserve and trauma surgeon to mentor military and civilian trainees, aligning with USUHS's mission to train uniformed health professionals.

Surgical Practice — Dr. Martin Schreiber was a skilled surgeon for severely injured or sick patients who required immediate treatment (surgical intervention) to save their lives. In addition to these interventions, he worked with patients in critical care settings and led trauma teams. His primary focus included the diagnosis and treatment of hemorrhagic shock and its associated conditions (coagulopathy) and resuscitative strategies to treat these conditions. Additionally, his experience treating traumatic injuries sustained during military conflict enhanced his expertise and knowledge base regarding the treatment of these types of injuries. Research — Dr. Martin Schreiber has contributed to the body of trauma research by conducting research and securing federal funding ($25 million) and industry funding (an additional $35 million) for projects that have generated millions of dollars in grant awards. He is also a mentor to residents and fellows/post-doctoral researchers and has published over 450 peer-reviewed manuscripts/book chapters/abstracts by 2025. Additionally, he has been the principal investigator on multiple studies funded by the Department of Defense (DoD) and the National Institutes of Health (NIH) on the use of whole blood transfusions, tranexamic acid (TXA), and hemostatic agents for the prevention/treatment of trauma-induced coagulopathy. Education — Dr. Martin Schreiber is an educator of medical students, residents and fellows and has been involved in directing education/training programs (i.e., Surgical Critical Care Fellowship Program). He has also had leadership roles in developing curricula and has trained dozens of trauma/critical care fellows and laboratory residents. Many of these individuals are now established leaders in academic medicine.